[1]
Cianniello, D. and Caputo, R. 2018. Patient with metastatic breast cancer, HER2-positive, trastuzumab- and pertuzumab-resistant responding to lapatinib: Paziente con carcinoma mammario metastatico, HER2-positivo, resistente a trastuzumab e pertuzumab ma responsivo a lapatinib. AboutOpen. 4, 1 (Jun. 2018), 66–68. DOI:https://doi.org/10.19156/abtpn.2018.0044.